ZOGENIX

At Zogenix, our core strategy is to develop and commercialize differentiated central nervous system (CNS) and pain therapeutics that can address significant unmet medical needs or overcome limitations of existing products. We are a specialty pharmaceutical company with two proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. Our lead product candidate, sumatriptan DoseProâ„¢, enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine. Our second product candidate, ZX002, is a novel controlled release formulation of hydrocodone for the treatment of chronic pain.

#SimilarOrganizations #People #Financial #Website #More

ZOGENIX

Social Links:

Twitter

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2006-01-01

Address:

San Diego, California, United States

Country:

United States

Website Url:

http://www.zogenix.com

Total Employee:

251+

Status:

Active

Contact:

1-858-259-1165

Email Addresses:

[email protected]

Total Funding:

1.49 B USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins

Similar Organizations

acadia-pharmaceuticals-inc-logo

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

aeovian-pharmaceuticals-logo

Aeovian Pharmaceuticals

Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.

apexian-pharmaceuticals-logo

Apexian Pharmaceuticals

Apex Therapeutics develops and commercializes pharmaceuticals for the treatment of cancer and ocular diseases.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

bionpharma-logo

BionPharma

BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.

glaxosmithkline-logo

GlaxoSmithKline

GlaxoSmithKline develops and markets products in the areas of pain relief, respiratory, digestive health, oral health, nutrition and skin.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

ultragenyx-pharmaceutical-logo

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Current Advisors List

erle-t-mast_image

Erle T. Mast Board of Directors @ Zogenix
Board_member

louis-bock_image

Louis Bock Board Director @ Zogenix
Board_member
2006-01-01

james-breitmeyer_image

James Breitmeyer Board Director @ Zogenix
Board_member
2012-03-01

erle-t-mast_image

Erle T. Mast Boards of Directors @ Zogenix
Board_member

kurt-wheeler_image

Kurt Wheeler Board of Directors @ Zogenix
Board_member
2006-08-01

jim-blair_image

Jim Blair Board Member @ Zogenix
Board_member
2006-08-01

Current Employees Featured

mike-smith_image

Mike Smith
Mike Smith EVP, Chief Financial Officer, Head of Corporate Development @ Zogenix
EVP, Chief Financial Officer, Head of Corporate Development
2017-01-01

alex-zisson_image